Effects of Calcium Channel Blockers on In Vitro Platelet Function in Whole Blood Using Single Platelet Counting

Summary

The effects of various calcium channel blockers on in vitro platelet aggregation were studied using whole blood platelet counting. Diltiazem and verapamil inhibited aggregation caused by adrenaline 5 μM and collagen 2 μg/ml, but only at concentrations far in excess of those seen in clinical use. Nifedipine and nimodipine also inhibited aggregation to these agonists, but this seemed to be due to the solvent used. The solvent for these dihydropyridines contains 15% ethanol, 15% polyethylene glycol and 70% water, and the ethanol component is the most likely to have caused an antiaggregatory effect. Other studies showing an antiaggregatory effect of dihydropyridines may not have taken account of this solvent effect.

Key words

Calcium channel blockers - Platelet aggregation - Solvents

• References

• 1 Ardlie NB. Calcium ions, drug action and platelet function. Pharmacol Ther 1982; 18: 249-270
• 2 Bums ER, Frishman WH. The antiplatelet effects of calcium channel blockers add to their antianginal properties. Int J Cardiol 1983; 4: 372-379
• 3 Jeremy JY, Barradas MA, Mikhailidis DP, Dandona P. An investigation into the effects of nifedipine and nimodipine on platelet function and vascular prostacyclin synthesis. Drugs Exp Clin Res 1985; 9: 645-651
• 4 Swart S, Pearson D, Wood JK, Barnett DB. Effects of adrenaline and a adrenergic agonists on platelet aggregation in whole blood: evalua-tion of platelet impedance aggregometry. Thromb Res 1984; 36: 411-418
• 5 Bevan J, Heptinstall S. Serotonin induced platelet aggregation in whole blood and the effects of ketanserin and mepyramine. Thromb Res 1985; 38: 189-194
• 6 Han P, Boatwright C, Ardlie N. Effects of calcium entry blocking agent nifedipine on activation of human platelets and comparison with verapamil. Thromb Haemostas 1983; 50: 513-517
• 7 Mehta JL. Influence of calcium-channel blockers on platelet function and arachidonic acid metabolism. Am J Cardiol 1985; 55: 158B-164B
• 8 Murphy MB, Orchard MA, Conway EL, Barrow SE. The effects of nifedipine on platelet aggregation and plasma 6-keto-PGF_1αand its interaction with indomethacin. Eur J Clin Pharmacol 1985; 29: 413-416
• 9 Braquet P, Shen TY, Torque L, Vargaftig BB. Perspectives in PAF research. Pharmacol Rev 1987; 39: 97-145
• 10 Jouvin-Marche E, Cerrina J, Coeffier E, Duroux P, Benveniste J. The effect of the calcium antagonist nifedipine on the release of platelet activating factor (PAF-acether) slow acting substance and a glucuronidase from human neutrophils. Eur J Pharmacol 1983; 89: 19
• 11 Takahara K, Kuroiwa A, Matsushima T, Nakashima Y, Takasugi M. Effects of nifedipine on platelet function. Am Heart J 1985; 109: 4-8
• 12 Mikhailidis DP, Jeremy JY, Barradas MA, Green N, Dandona P. Effects of ethanol on vascular prostacyclin (PGI 2) synthesis, platelet aggregation and platelet thromboxane release. Br Med J 1983; 287: 1495-1496